Citigroup’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,100
Closed -$61K 8007
2018
Q4
$61K Sell
1,100
-800
-42% -$43.4K ﹤0.01% 6079
2018
Q3
$88K Sell
1,900
-3,600
-65% -$174K ﹤0.01% 6030
2018
Q2
$265K Buy
5,500
+2,300
+72% +$110K ﹤0.01% 4776
2018
Q1
$139K Sell
3,200
-83,500
-96% -$3.75M ﹤0.01% 5312
2017
Q4
$3.44M Buy
86,700
+5,500
+7% +$229K ﹤0.01% 2182
2017
Q3
$3.52M Sell
81,200
-134,800
-62% -$6.15M ﹤0.01% 2078
2017
Q2
$10.3M Buy
216,000
+215,800
+107,900% +$10.1M 0.01% 1124
2017
Q1
$8K Sell
200
-9,800
-98% -$409K ﹤0.01% 6659
2016
Q4
$384K Buy
+10,000
New +$406K ﹤0.01% 4658
2013
Q4
Sell
-15,000
Closed -$630K 7242
2013
Q3
$630K Buy
+15,000
New +$714K ﹤0.01% 3251

Citigroup's IMPV Position: Q1 2019 in Review

Citigroup sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 22,663 shares — an estimated $1.26M sold.

Citigroup first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $20.6M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Citigroup reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 22,663 Imperva, Inc. shares in Q1 2019, an estimated $1.26M.
  • Citigroup first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Citigroup's Imperva, Inc. position peaked at $20.6M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.